Development of effective (trans)dermal drug delivery systems requires reliable skin models to evaluate skin drug penetration. The isolated perfused human skin flap remains metabolically active tissue for up to 6 h during in vitro perfusion. We introduce the isolated perfused human skin flap as a close-to-in vivo skin penetration model. To validate the model's ability to evaluate skin drug penetration the solutions of a hydrophilic (calcein) and a lipophilic (rhodamine) fluorescence marker were applied. The skin flaps were perfused with modified KrebsHenseleit buffer (pH 7.4). Infrared technology was used to monitor perfusion and to select a well-perfused skin area for administration of the markers. Flap perfusion and physiological parameters were maintained constant during the 6 h experiments and the amount of markers in the perfusate was determined. Calcein was detected in the perfusate, whereas rhodamine was not detectable. Confocal images of skin cross-sections shoved that calcein was uniformly distributed through the skin, whereas rhodamine accumulated in the stratum corneum. For comparison, the penetration of both markers was evaluated on ex vivo human skin, pig skin and cellophane membrane. The proposed perfused flap model enabled us to distinguish between the penetrations of the two markers and could be a promising close-to-in vivo tool in skin penetration studies and optimization of formulations destined for skin administration.
Introduction
(Trans)dermal delivery of drugs and cosmeceuticals has gained increasing interest in pharmaceutical and cosmetic fields. The skin represents an attractive route of drug delivery for both local and systemic effects. In this context, investigating the drug penetration into/through the skin is of fundamental importance regarding both the desired drug's therapeutic efficacy and its potential toxicity (DeLouise, 2012; Prow et al., 2011) . Skin, especially the stratum corneum (SC) layer, exhibits very efficient barrier properties which limit drug penetration into/ through the skin and needs to be overcome for successful trans(dermal) delivery (Bouwstra et al., 2003; Lane, 2013) . Therefore, reliable skin models able to predict and evaluate the (desired or undesired) penetration of molecules/nanosystems in vivo and serve as a tool in optimization of topical formulations are required (Flaten et al., 2015) . In vivo studies, especially in humans, are the golden standard tool in skin penetration studies. However, in the early stages of drug development, in vivo studies are restricted due to ethical and economical concerns (Parra et al., 2016) . Moreover, new regulations limit the use of animals for in vivo studies in the initial stages of product development (Flaten et al., 2015) . Therefore, in vitro and ex vivo techniques are gaining more interest as tools to study skin penetration (Patel et al., 2016) .
The skin perfusion models comprise a surgically prepared portion of skin (flap) including subcutaneous fatty tissue with assured continuous vascular circulation. These models offer the benefits of living metabolically-active tissue and are considered the missing link between in vitro and in vivo methods (Schaefer et al., 2008) . These models overcome some of the limitations of the in vitro studies using human or animal skin, such as the use of only epidermis and the upper part of the dermis and the lack of a dermal vascular system (de Lange et al., 1992; Patel et al., 2016) . Several animal specimens have been used for the skin perfusion model, such as the isolated perfused pig skin flap (Riviere et al., 1986) , the isolated blood-perfused pig ear (de Lange et al., 1992) , the isolated perfused bovine udder (Kietzmann et al., 1993) and the pig forelimb (Wagner et al., 2003) . Pig skin is considered the most suitable animal model to mimic human skin. Therefore, pig skin flap has been widely studied as skin perfusion model and skin penetration of different substances has been investigated using the isolated perfused pig skin flap model (Carver et al., 1989 Williams et al., 1990; Wester et al., 1998; Inman et al., 2003) .
However, use of animal skin retains the limitations of correlations between animal and human skin. Kreidstein et al. (1991) designed the isolated perfused human skin flap model using transverse paraumbilical skin flap. This tissue is normally discarded in abdominal dermolipectomy (Kreidstein et al., 1991) . Several techniques have confirmed the perfusion of the flap (Black et al., 2001; Kreidstein et al., 1995; Lipa et al., 1999; Miland et al., 2008) . Miland et al. (2008) confirmed the suitability of the dynamic infrared thermography (DIRT) to monitor skin flap perfusion and to differentiate between well and less perfused areas.
To the best of our knowledge, the isolated perfused human skin flap (IPHSF) has not been used to study (trans)dermal penetration. Such a model could be a valuable tool in skin penetration studies and in optimization of dosage forms/delivery systems for skin therapy.
This study evaluated the feasibility of the IPHSF as a skin penetration model. To validate the IPHSF model, two fluorescent markers, a hydrophilic (calcein) and a lipophilic (rhodamine), were used and their penetration investigated over a 6 h period. Confocal laser scanner microscopy (CLSM) technique was used to follow the fluorescent markers penetration through the IPHSF. These data were compared with the ex vivo (human and pig skin) and in vitro (cellophane membrane) penetration studies in Franz diffusion cells (FDC).
Material and methods

Material
Calcein, rhodamine B, sodium chloride, potassium chloride, magnesium sulfate, sodium bicarbonate, trichloroacetic acid ( ≥99.0%), ethanol (96%, v/v) and Triton™ X-100 were from Sigma-Aldrich Chemie (Steinheim, Germany); human serum albumin (30 mg/mL) from Octapharma AG (Lachen, Switzerland); propylene glycol (PG) from NMD -Norwegian Medical Depot AS (Oslo, Norway) and glucose, calcium chloride and potassium dihydrogen phosphate from Merck KGaA (Darmstadt, Germany). Sucrose was product of VWR International bvba/sprl (Leuven, Belgium). Pig ears were purchased from Nurtura AS (Bardufoss, Norway).
Human skin flap
Eight human skin flaps were used in this study and were obtained from the abdomen of female patients (mean age 49.5 years, range 40-66 years) who underwent abdominoplasty (Table 1 ). All patients gave their written consent prior to the surgery and the experiments were performed according to the Declaration of Helsinki Principles. Since these skin panni are normally disposed of by incineration, no ethical approval for their use was required according to Norwegian Ethical Committee. The procurement and disposal of human skin flaps were in accordance with the policy of the University Hospital of North Norway, Tromsø.
Preliminary perfusion experiment
A modification of the perfusion design of the model described by Miland et al. (2008) was used. The human skin flap, after its excision, was wrapped in gauze soaked with physiological solution and placed in a sealed plastic box to maintain it at room temperature until it was transferred in the laboratory where the flap experiments were performed. To perfuse the human skin flap, it was placed on a metal grid and one vessel was selected and cannulated with an arteriotomy cannula (diameter 1 mm; DLP® Metronic Inc., Minneapolis, USA), which was then connected to the perfusion apparatus (Fig. 1) . The cannulation was performed at room temperature. The perfusate was modified KrebsHenseleit buffer (KHb) comprising (in mM): 110 NaCl, 3.8 KCl, 1.4 KH2PO4, 1.2 MgSO4, 31 NaHCO3, 2.5 CaCl2, 11 glucose and 10 sucrose. Human serum albumin (30 mg/mL) was added to the perfusate. The perfusate had a pH of 7.4 and an osmolarity of 290 mOsm mimicking the physiological conditions.
The perfusion flow rate (6-8 mL/min) was monitored using a drop counter and the pressure by inline pressure transducer (Transpac® IV; Abbott Laboratories, North Chicago, IL, USA).
All perfusions were initiated within 90 min after the excision of skin panni (Miland et al., 2008) .
Validation of the IPHSF model
Preliminary calcein skin penetration experiments through the IPHSF were performed to validate the experimental setups and the analytical method of the quantification of penetrated marker in the perfusate. Calcein solution (10 mM) in KHb was applied onto the perfused skin flap (Fig. 1) . The skin diffusion area (49 cm 2 ) exhibiting best perfusion (skin temperature of ca. 32°C) was measured with an IR camera (FLIR ThermaCAM S65 HS, FLIR Systems). An adhesive patch constituted the donor chamber and calcein solution (7 mL) was applied onto the selected well-perfused skin area using a syringe. The experiment was carried out for 6 h when no leakage of the solution was observed. The weight of the flap was determined before and after the perfusion period. The penetrated calcein was assessed spectrofluorometrically in the perfusate collected after 6 h from a metal container placed under the flap. To assure that no inherent fluorescent skin constituents were detected, the perfusate was also collected when calcein solution was applied (time 0). Moreover, the non-penetrated calcein (retained on the flap surface) was swept and quantified at the end of experiment. a Weight and thickness of the flaps were not determined in the preliminary study used to validate the experimental design of the perfusion technique and experimental set up. b Thickness (cm) refers to the full skin obtained from the human skin flap. Weight was not determined since not relevant for ex vivo study.
Quantification of calcein in the perfusate
The analytical method used to detect and quantify calcein in the perfusate was based on Bahia et al. (2010) with modifications. The collected perfusate was centrifuged to remove blood cells (1914 g, 20 min). To assure that no calcein precipitated with the blood cells the pellets were firstly washed with KHb (10 mL) and secondly dissolved in Triton solution 5% (w/v; 10 mL). Trichloroacetic acid (58.82%, w/v) was used to precipitate plasma protein. Calcein concentrations in the supernatants, pellets washed after blood cells precipitation and pellets dissolved in Triton solution were determined spectrofluorometrically (excitation and emission wavelengths at 485 and 520 nm, respectively) on a Polarstar fluorimeter (Fluostar; BMG Technologies, Offenburg, Germany) using a multiplate reader (COSTAR 96). Three parallels were determined for each sample. Eq. (1) (derived from the Fick's first law) was used to calculate the apparent permeability coefficient (P app ) where J is the observed flux rate (μg/cm 2 /s) and C d is the concentration of calcein solution in the patch (μg/mL). The flux was calculated from the linear part of the curve, representing the steady-state condition.
Skin penetration experiments on IPHSF model
Calcein (10 mM) in KHb and rhodamine (10 mM) in KHb/PG (0.5%, v/v) were applied onto the skin flaps perfused with KHb (Fig. 1) . The weight and thickness of each flap were determined before and at the end of the experiment. The perfusate was collected at time 0 and every hour for a period of 6 h and sink conditions were maintained. The penetrated and non-penetrated markers were quantified as described in the methods for validation of the IPHSF model.
Confocal laser scanning microscopy (CLSM)
CLSM analysis was performed on a Leica TCS SP5 microscope (Leica Microsystems CMS GmbH, Mannheim, Germany) equipped with an Argon laser. The samples were prepared using the imprint method (Brommeland et al., 2003) . A cross-sectioned slide of the flap was cut by a scalpel and attached onto a microscope slide. The cells remaining on the slide were fixed in formalin (SPRAYFIX®, Histolab Products AB, Gothenburg, Sweden). The flap areas used in CLSM are shown in Fig.  2a . Calcein and rhodamine were excited using 488 and 568 nm laser lines, respectively. Fluorescence was detected using the following spectral range: 500-550 nm for calcein, 570-610 nm for rhodamine. When required, images were acquired in Z-sections of 1 to 100 μm thickness and were superimposed.
Ex vivo and in vitro skin penetration experiments
Ex vivo and in vitro skin penetration experiments were carried out on Franz diffusion cells (FDC; PermeGear, Bethlehem, USA) of 1.77 cm 2 diffusion area and with 12 mL receiver volume (Hurler et al., 2012) . Ex vivo skin penetration experiments were performed using human skin (HS) and pig ear skin (PS). Human skin (HS) was obtained from human skin flaps, which were not the same as the flaps used in skin penetration experiments on IPHSF model (Table 1) . Cellophane membrane (CM; Max Bringmann KG, Wendelstein, Germany) was employed in in vitro experiments. The same solutions of the fluorescent markers tested in the IPHSF were added into the donor chamber (600 μL). The receiver chamber was filled with KHb. Samples (500 μL) were collected at 1, 2, 4 and 6 h and replaced by fresh acceptor medium to maintain sink conditions. All experiments were carried out at 32°C. Calcein and rhodamine concentrations were determined spectrofluorometrically. Eq. (1) was used to calculate the P app . Fig. 1 . Flap perfusion design. The perfusate was filtered and gassed with 95% O 2 /5% CO 2 using a rotating surface oxygenator. The perfusion flow rate (6-8 mL/min) was monitored using a drop counter and the perfusion pressure measured with an inline pressure transducer. A heating circulator was set at 38°C and a thermocouple inserted in the cannula to monitor the temperature of the perfusate entering the flap. The IR camera monitored the skin surface temperature throughout the perfusion period. The flow, pressure and temperature of the perfusate were monitored on-line using PhysAcq software. The perfusate from IPHSF was collected using a metal container.
Statistical evaluation
The Student's t-test was used for the comparison of two means. A significance level of p b 0.05 was considered significant.
Results
Any model destined for application in the development and optimization of skin formulations needs to be validated to confirm its robustness and wider applicability. Table 1 provides an overview of the characteristics of the flaps used in experiments. The perfusion experimental set up of Miland et al. (2008) was modified to identify the areas of the flap with skin temperature of at least 32°C corresponding to adequate perfusion (Fig. 1) . This enabled us to establish the area (49 cm 2 ) of well-perfused skin surface suitable to apply fluorescent markers. Once the area was selected, we focused on optimizing the volume (mL) of the marker solution to be applied. Calcein solution (7 mL) was injected into an adhesive patch (donor chamber) attached to the selected well-perfused skin area and penetration studies performed to further validate the model and confirmed its applicability.
Validation of IPHSF model
The IPHSF was further validated in respect to possible oedema formation and the weight changes. Variation of b 10% in the weight observed during 6 h of perfusion was found acceptable (data not shown).
Calcein was detected in the perfusate. Moreover, in the perfusate collected at time 0 no fluorescence was detected, indicating that no inherent fluorescent skin constituents were present in the perfusate and could be detected spectrofluorometrically.
Assuring perfusion during the skin penetration studies
Physiological parameters were monitored throughout the experiment. The flow, perfusion pressure and inlet temperature were kept constant during 6 h ( Table 2) .
All areas where the markers were applied were well perfused throughout the experiment and no leakage of markers from the donor chambers were observed (Fig. 2a) . DIRT images, taken 1 min after the start of the perfusion, showed a hot spot indicating where the skin perfusion started (Fig. 2b) . A distinct area of rewarming appeared corresponding to the perfusion area of the cannulated vessel. DIRT images were also taken before and after the application of markers (Fig. 2c ) and confirmed well-perfused skin in areas where the markers were applied throughout the experiment (Fig. 2d, e) .
Penetration of fluorescent markers in IPHSF model
DIRT images of flap areas where markers were applied showed that the area was still perfused after 6 h. Interestingly, DIRT images of flap areas next to where rhodamine was applied showed also the less wellperfused area (skin surface temperature lower than 32°C) (Fig. 2e) . To further investigate this area, a cross-section of the area was analyzed by CLSM. CLSM images of the marker-free skin area showed no presence of both markers, as expected (Fig. 3a) . CLSM images of calcein (green) in the perfused-treated area indicated a uniformly distributed fluorescence through the skin flap, while rhodamine (red) exhibited a bright fluorescence in the SC but decreasing fluorescence in the viable epidermis and subcutaneous fat tissue (Fig. 3b) . CLSM images of both markers in the well-perfused-untreated area indicated a weaker fluorescence as compared to the treated area (Fig. 3c) . In the less well-perfused areas we could only detect a weak fluorescence of rhodamine (Fig. 3d) .
CLSM images confirmed the skin penetration profiles of the two markers in the IPHSF model. 
Correlation between the skin penetration in the IPHSF model and ex vivo and in vitro studies
Penetration of two markers through IPHSF model is presented in Fig.  4a . No fluorescence was detected in the perfusate at time 0, assuring that no inherent skin constituents were detected with our analytical method employed to quantify the penetrated markers in the perfusate. Calcein was detected in the perfusate, whereas rhodamine was not detectable. Ex vivo skin penetration studies using human skin revealed lower calcein penetration as compared to IPHSF (p b 0.05) (Fig. 4b) . The same penetration profiles of rhodamine were observed both in the IPHSF and in ex vivo studies on human skin (Fig. 4a, b) . More calcein and rhodamine penetrated through the pig skin and cellophane membrane compared to the ex vivo human skin and the IPHSF (Fig. 4c, d) . Calcein exhibited higher flux and P app than rhodamine; whereas the non-penetrated rhodamine was recovered to higher extent (Table 3) .
Discussion
The organization of the lipid domains in the SC is considered the main contributor to the barrier property of the skin (Bouwstra et al., 2003; Schmieder et al., 2015) . This barrier property of the skin can be seen as a synergy between the cooperation and interactions between SC macro-and micro-structure, bi-and three-dimensional supramolecular organization of the lipid matrix and composition of the SC (Baroli, 2010) . However, dermal circulation is responsible for the clearance of the drug from the skin and should not be neglected (Lane, 2013) . The introduction of nanocarriers has opened a means to improve penetration of drug into/through the skin. Nanoparticles are expected to enhance or limit the ingress and diffusion of drugs into/through the skin depending on their physicochemical properties, particularly size .
Consequently, there is an increasing need to understand the penetration into/through the skin and the interaction between the carrier, drug and the skin not only to optimize the therapeutic applications, but also to minimize potential side effects (Bolzinger et al., 2012; DeLouise, 2012) . However, reliable skin models able to predict and investigate desired or undesired penetration through the skin remain challenging. Human skin perfusion models offer the benefits of living tissue with active microcirculation, mimicking the application in human to a greater extent (Schaefer et al., 2008; Patel et al., 2016) . Moreover, they provide a mean to study the effects of dermal vasculature on the systemic absorption. However, no human skin perfusion model has been used to assess the penetration of drugs/markers into the skin and as a tool in dermatological product development. Kreidstein et al. (1991) have shown that the human skin flap is metabolically and physiologically stable for at least 5 h of in vitro perfusion. We used DIRT to measure skin perfusion. A number of studies have shown a good correlation between skin temperature and skin perfusion. As such DIRT can provide us indirectly with information on skin perfusion and its dynamics (de Weerd et al., 2006 (de Weerd et al., , 2009 .
The perfusion of IPHSF was performed using the established method by Miland et al. (2008) with modifications. To validate the model, preliminary skin penetration studies were performed on perfused skin flaps in order to establish the experimental design of skin penetration studies on IPHSF. In both preliminary and skin penetration studies, we observed the same dynamics of perfusion. This confirmed that experimental conditions remained constant throughout the experiments. Moreover, little variation (b10%) in the weight and thickness of all flaps during 6 h perfusion excluded oedema formation and assured a good tissue perfusion as reported earlier (Black et al., 2001; de Lange et al., 1992; Lipa et al., 1999) . Similar to Miland et al. (2008) a perfusion flow rate between 6 and 8 ml/min was maintained during the experiments. The perfusion pressure was higher than 50 mmHg, which we attribute to the smaller cannula diameter and the different software used to monitor the baseline perfusion in our experiments as compared to Miland et al. (2008) .
The IPHSF model was able to distinguish between the penetrations of two markers (0.7% calcein and 0% rhodamine). Calcein penetrated to a lower extent, as expected, since it is a hydrophilic marker with low logP (−5.02) (Gillet et al., 2011) with limited skin penetration potential (Bolzinger et al., 2012) . Interestingly, calcein was detected in the perfusate, which would suggest that the circulation enabled its penetration. Rhodamine has a higher logP (1.95) (Anissimov et al., 2012) and due to its lipophilicity was prepared in solution containing PG (0.5%; v/v) as a solubilizing agent. Therefore, we expected that PG would act as a penetration enhancer (Lane, 2013) . However, the concentration of PG used in our study was relatively low compared to the PG concentration used in other studies suggesting its role as penetration enhancer (Trottet et al., 2004; Watkinson et al., 2009) . Similar penetration results were reported by Wester et al. (1998) and their studies on the isolated perfused pig skin flap model. Tested compounds with lower logP were detected in higher percentage in the perfusate compared to compounds with higher logP. Although we could not detect rhodamine in the perfusate, the amount of rhodamine retained at the administration site on the flap was less than calcein. This suggests that rhodamine remained within SC rather than penetrating deeper into epidermis, as expected (Bolzinger et al., 2012) . The extracellular space in SC and stratum granulosum exhibits hydrophobic properties due to its lipid-rich composition, whereas the layers below the stratum granulosum represent hydrophilic environment due to desmosome-rich composition (Iwai et al., 2012; Schmieder et al., 2015) . The IPHSF results were supported by the CLSM images of the cross-section of skin flaps. While calcein was found uniformly distributed throughout the flap, rhodamine exhibited a bright fluorescence in the SC but weaker fluorescence in the viable epidermis and subcutaneous fat tissue. Gillet et al. (2011) reported similar accumulation of rhodamine in the SC and negligent amount within the epidermis. The same penetration profile of rhodamine observed in the IPHSF model was seen in full human skin in FDC. Water present on the surface of skin might cause swelling of the polar head-group regions in the lipid bilayers, and hence disruption of the lipid domains, which could explain the higher fluxes of hydrophilic molecules such as calcein (Bolzinger et al., 2012) . However, the percentage of penetrated calcein through full human skin in FDC was significantly lower (p b 0.05) than through the IPHSF model indicating that the perfusion might play an important role in the penetration of compounds through the skin, as recently suggested by Patel et al. (2016) . For the hydrophilic marker calcein we observed a positive effect of perfusion on its skin penetration, whereas for the lipophilic marker rhodamine the penetration profile was not influenced by the perfusion to a greater extent. These results support considerations that ex vivo skin studies do not resemble the in vivo situations to a satisfactory extent. This is a clear advantage of the skin perfusion models, since these models investigate the drug penetration considering also the dermal perfusion (Schaefer et al., 2008) . Wagner et al. (2002) also reported that hydrophobic flufenamic acid penetrated less through the human skin in FDC system than in in vivo studies. We confirmed that the perfusion played a role in the penetration of both markers by analyzing cross-section of perfused skin flap areas where the markers were not applied (as visible by DIRT images). CLSM images of these untreated perfused areas showed the presence of both markers in the skin and subcutaneous tissue of untreated areas confirming that perfusion affected the penetration. Such findings stress the importance of perfusion in a skin penetration model.
The results obtained with the IPHSF model were compared with the results obtained on the established skin models. Both penetration studies through the pig skin and cellophane membrane showed a higher penetration of the markers compared to their penetration through the IPHSF model and human skin in FDC system, strongly indicating the importance of having a model that contains human skin. Interestingly, calcein penetrated through pig skin more than rhodamine. Observed P app of calcein across pig skin was similar as in an established in vitro model mimicking human SC lipid composition (Engesland et al., 2013) . Rhodamine penetration through the pig skin, IPHSF model and human skin on FDC system was similar and as expected since it is known that pig skin mimics human skin better for the lipophilic penetrants (Dick and Scott, 1992) . Penetration of both markers through cellophane membrane was significantly higher than in other models used in this study (p b 0.05); calcein penetrated more than rhodamine in agreement with Ansari et al. (2006) who tested the penetration of three drugs with different lipophilicity through human skin, cellophane and natural membranes. They found that penetration of water soluble diclofenac sodium through cellophane was higher than through all other membranes, while penetration of lipophilic erythromycin through cellophane was lower (Ansari et al., 2006) .
Although different in vitro and ex vivo animal skin models help us to simplify the drug penetration, the results obtained from those models differ from the results obtained with IPHSF model suggesting the importance of this missing link in reaching the close-to-in vivo situation.
The limitation of this study is the relatively small number of experiments; therefore, the results should be interpreted within the context of this limitation. Moreover, the IPHSF model is metabolically active for 6 h and skin drug penetration studies on IPHSF model have to be performed within this time limit. Specific equipment, such as infrared camera, is needed to perform skin flap experiments as well as the help of selected professionals to cannulate the skin flap. Therefore, we are aware that the IPHSF model cannot be used as skin perfusion model in the early stages of drug development. However, the model might be used, after the fully validated methodologies have been employed, to study skin drug penetration in conditions closer to the in vivo human ones since the importance of perfusion and the use of human skin in skin penetration studies is clear.
The next step in full utilization of the proposed model is to evaluate the penetration of nanoparticles and nanoparticle-associated drugs.
Conclusions
We demonstrated that the isolated perfused human skin flap model can be used in the skin penetration studies since it provides constant experimental conditions and perfusion, assuring reproducible results. Moreover, the model proves the benefits of working with living tissue using a byproduct of surgery, and avoiding animal use. The model was able to distinguish between the penetrations of two markers and is a promising tool in optimization of formulations destined for skin administration.
